First results of our cooperation with University of Pittsburgh Medical Center, UPMC, were presented during the ESC congress 2022 in Barcelona by Prof. Dr. Guy Salama in the session
“HFpEF and HFmrEF: what’s new in treatment” – “The therapeutic potential of relaxin for heart failure with preserved ejection fraction”
You will learn about relaxin-2 – Wnt1-interaction and gain insight into relaxin’s pleitropic actions and its ability to reverse maladaptive remodeling of atrial tissue and suppress fibrosis.
Read the abstract here.